Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Life Insurance Strategies

WellPoint To Pay For Anti-Shingles Shots

Your article was successfully shared with the contacts you provided.

A giant managed care company says it will add Zostavax, a vaccine that protects recipients against the chickenpox virus, to its vaccine benefits program.

WellPoint Inc., Indianapolis, says it will cover the vaccine for individuals 60 years of age and older whose plans provide vaccine coverage.

The vaccine can keep older individuals from developing a shingle, a painful condition that results from reactivation of the chickenpox virus.

WellPoint says it is adding Zostavax benefits because of an announcement that the federal Advisory Committee on Immunization Practices has recommended that the Zostavax vaccine be offered to all U.S. residents ages 60 and older.


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.